marketcap
Facebook
Twitter
Telegram
Report an ErrorQuarterly report 2024-Q3
added 11-08-2024
Xeris Pharmaceuticals Financial Ratios 2011-2024 | XERS
Annual Financial Ratios Xeris Pharmaceuticals
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
P/E |
-5.5 | -1.9 | -1.5 | -2.6 | -1.2 | -3.0 | - | - | - | - | - | - | - |
P/S |
2.1 | 1.6 | 3.8 | 11.5 | 57.1 | 72.9 | - | - | - | - | - | - | - |
EPS |
-0.5 | -0.7 | -1.6 | -2.1 | - | - | - | - | - | - | - | - | - |
EV (Enterprise Value) |
605 M | 359 M | 330 M | 360 M | 250 M | 224 M | 103 M | 65.5 M | - | - | - | - | - |
EBITDA per Share |
-0.31 | -0.59 | -1.44 | -1.78 | -4.65 | -4.9 | - | - | - | - | - | - | - |
EV/EBITDA |
-2.6 | -3.5 | -1.6 | -2.8 | - | - | - | - | - | - | - | ||
PEG |
- | -0.05 | -0.34 | 0.03 | - | - | - | - | - | - | - | ||
P/B |
-50.5 | 4.0 | 2.0 | 6.9 | 10.8 | 2.4 | - | - | - | - | - | - | - |
P/CF |
-7.3 | -1.8 | -2.0 | -2.9 | -1.5 | -3.1 | - | - | - | - | - | - | - |
ROE % |
917.94 | -209.49 | -128.87 | -269.96 | -869.91 | -79.68 | - | - | - | - | - | - | - |
ROA % |
-19.30 | -27.48 | -40.32 | -57.27 | -115.22 | -50.05 | - | - | - | - | - | - | - |
ROCE % |
648.92 | -181.34 | -120.92 | -63.80 | -149.89 | -54.02 | - | - | - | - | - | - | - |
Current Ratio |
1.0 | 1.2 | 1.5 | 5.4 | 3.2 | 11.6 | - | - | - | - | - | - | - |
DSO |
78.0 | 79.9 | 64.2 | 122.8 | 756.1 | 424.8 | - | - | - | - | - | - | - |
DIO |
405.0 | 345.5 | 248.3 | 326.8 | 495.5 | - | - | - | - | - | - | - | - |
DPO |
103.0 | 109.1 | 122.3 | 122.0 | 1275.8 | 7526.0 | - | - | - | - | - | - | - |
Operating Cycle |
483.0 | 425.5 | 312.5 | 449.6 | 1251.6 | 424.8 | - | - | - | - | - | - | - |
Cash Conversion Cycle |
380.0 | 316.4 | 190.2 | 327.7 | -24.2 | -7101.1 | - | - | - | - | - | - | - |
All numbers in USD currency
Quarterly Financial Ratios Xeris Pharmaceuticals
| 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
EPS |
-0.11 | -0.1 | -0.14 | - | -0.09 | -0.14 | -0.12 | - | -0.16 | -0.19 | -0.25 | - | -0.39 | -0.41 | -0.3 | - | -0.35 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
EBITDA per Share |
-0.07 | -0.04 | -0.1 | - | -0.02 | -0.1 | -0.09 | - | -0.12 | -0.12 | -0.21 | - | -0.35 | -0.38 | -0.27 | - | -0.28 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROE % |
24.80 | -346.14 | -569.40 | -516.85 | -556.51 | -280.81 | -170.76 | -110.03 | 946.82 | 2043.33 | 1940.39 | 877.02 | 829.63 | -274.61 | -235.11 | -254.05 | -254.05 | -206.66 | -107.81 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROA % |
-18.78 | -17.60 | -19.11 | -14.99 | -22.20 | -25.68 | -27.87 | -25.41 | -45.22 | -57.83 | -49.62 | -19.81 | -29.87 | -20.11 | -20.11 | -10.05 | -10.05 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROCE % |
116.06 | -56.57 | -216.16 | -288.44 | -322.56 | -229.57 | -138.01 | -89.85 | 899.92 | 1923.80 | 1819.72 | 822.39 | 781.68 | -248.79 | -119.13 | -40.71 | -40.71 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Current Ratio |
0.9 | 0.9 | 1.0 | 1.0 | 1.0 | 1.0 | 1.1 | 1.1 | 1.2 | 1.3 | 1.4 | 1.5 | 1.0 | - | - | 1.3 | 1.3 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DSO |
70.3 | 75.8 | 86.0 | - | 71.9 | 73.3 | 84.8 | - | 81.8 | 88.6 | 84.4 | - | 55.9 | - | 38.3 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DIO |
295.7 | 491.1 | 609.1 | - | 415.5 | 396.0 | 461.3 | - | 329.7 | 329.7 | 254.5 | - | 201.8 | - | 208.7 | - | 134.6 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
44.5 | 75.5 | 142.6 | - | 131.8 | 142.6 | 142.3 | - | 91.5 | 168.1 | 145.6 | - | 60.8 | - | 77.9 | - | 50.2 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Cycle |
366.0 | 566.9 | 695.1 | - | 487.4 | 469.4 | 546.0 | - | 411.4 | 418.3 | 338.9 | - | 257.7 | - | 247.0 | - | 134.6 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cash Conversion Cycle |
321.5 | 491.4 | 552.5 | - | 355.6 | 326.8 | 403.8 | - | 320.0 | 250.2 | 193.3 | - | 196.9 | - | 169.1 | - | 84.3 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency